Biogen Exercises Samsung Bioepis Call Option - Summary & Implications
Samsung Biologics Co., Ltd (207940 KS) said in a regulatory filing that Biogen Inc (BIIB US) exercised Bioepis call option. Link of this...
267 Views
The Week That Was In North Asia@Smartkarma: Won Depreciation, Mercari, & 11st Spin-Off & Investment
It has been an eventful week in North Asia. The biggest story was the hugely successful IPO of Mercari in Japan. In Korea, SK Telecom continued its...
153 Views
Why Is the Moon Administration So Anti-Samsung?
It has been more than a year since Moon Jae-In has become the President of South Korea. Since this period, it has been becoming more apparent that...
144 Views
Korea Stock Market Monthly Recap #25 (May 2018)
May was a month full of surprises. The biggest surprise may have been the cancellation of the meeting with Kim Jong-Un by Trump, only to have Moon...
131 Views
Some Thoughts on Samsung's Holding Company Conversion Scenario (Part 4 of 4)
In April 2017, Samsung announced it would not create a Holdco structure. This could be for two reasons – (1) Samsung Electronics might be...
222 Views